The ability of the PPA family to hydrolyze PPi or dephosphorylate its protein substrate has been reported to be modulated by the same active site of the enzyme (Tezuka et al, 2013), which may explain why the ability of PPA2 in CRC relies on its enzymatic activity, as previously proven. The gene discussed is PPA2; the disease is colorectal carcinoma.